To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
Charles River Laboratories International, Inc. announced the ability to conduct preclinical cancer research using ITCC-P4’s well-characterized collec...
QIAGEN announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus (EBV), or human herpes virus 4, is estimated in ...
At the annual Materials Science and Technology (MS&T23) conference, Bruker Corporation (Nasdaq: BRKR) announced the release of the Hysitron TI 99...
QIAGEN announced the expansion of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), to include artificial in...
QIAGEN announced the extension of its eco-friendlier QIAwave product line with the addition of two new nucleic acid extraction kits: the QIAwave RNeasy Plu...
Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies that help to improve patie...
These models are essential for testing in vivo efficacy of novel therapeutics against lung cancer, elevating the prospects for significant advances in the ...
Expanded collaboration to help drive research productivity in labs with unique, iPaaS-based approach to data integration Revvity Signals Software adds n...
STARLIMS, a leading provider of enterprise informatics solutions, announces the expansion of its solution suite through the strategic acquisition of Labste...
Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic r...
This post continues the discussion of optimization opportunities for GC labs, focusing on headspace sampling for the efficient and automated analysis of vo...
American Institute of Pathology & Laboratory Sciences (Ampath) Expands with Second Reference Lab in India Ampath, known as the American Institute of P...
Highlights: Reported revenue of $1.67 billion declined 2.7% year-over-year, and decreased 2.3% on a core(1) basis. GAAP net income of $111 millio...
© 2025 Biopharma Boardroom. All Rights Reserved.
